Latest Posts

19 Jan 2019

ELECTRONICS INDUSTRY WANTS A SLICE OF THE HEALTHCARE REVENUE PIE

By Eric Taub If the scores of personal health care devices at the Consumer Electronics Show in January are any indication, it’s clear that the Apple Watch has kicked off a rush by high-tech companies to capitalize on people’s worries about their health. The latest version of the watch, which was

0
14 Jan 2019

GET OUT OF THE WAY OPIOIDS, METH IS MAKING A BIG, DEADLY COMEBACK

By Carmen Heredia Rodriguez In 2016, news reports warned the public of an opioid epidemic gripping the nation. But Madeline Vaughn, then a lead clinical intake coordinator at the Houston-based addiction treatment organization Council on Recovery, sensed something different was going on with the patients she checked in from the

0
14 Jan 2019

MEDTRONIC SETTLES DOJ CLAIMS LODGED AGAINST ACQUIRED FIRMS FOR $50.9M

  Medtronic has agreed to pay the U.S. Department of Justice $50.9 million to resolve three claims against Covidien and ev3, two companies Medtronic acquired in 2015. One payment is for $13 million and settles the DOJ’s investigation of the STRATIS Registry, which was designed to assess clinical outcomes of Covidien’s

0
09 Jan 2019

PENUMBRA ACQUIRES 90% OF MVI HEALTH, LAUNCHES 2 ENHANCED THROMBECTOMY TOOLS

Penumbra has acquired 40 percent of the outstanding shares of virtual reality joint venture MVI Health from collaborator Sixense, boosting its interest to 90 percent, and said it launched the Penumbra Jet 7 and Jet D reperfusion catheters. The joint venture intends to commercialize healthcare applications of virtual reality technology, Alameda,

0
09 Jan 2019

ENDOLOGIX RECALLS NELLIX SYSTEM FOR PATIENT SAFETY

Endologix Inc., a developer and marketer of treatments for aortic disorders, has stopped unrestricted sales and use of the Nellix System in order to ensure optimal outcomes for patients. The existing inventory will be voluntarily recalled as described in a Field Safety Notification (FSN) issued in January. The Nellix System

0
SHARE

Home